Changeflow GovPing Courts & Legal Agency Information Collection Activities; Propo...
Routine Notice Amended Consultation

Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Drug Use Statement

Favicon for www.federalregister.gov FR: Justice Department
Published
Detected
Email

Summary

The Department of Justice, through the Drug Enforcement Administration (DEA), has published a notice in the Federal Register seeking public comments on proposed revisions to the Drug Use Statement information collection (OMB No. 1117-0063). The notice requests eComments through Regulations.gov as part of the standard PRA process for revising a previously approved collection. The comment period closes June 16, 2026.

Published by Justice Department on federalregister.gov . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

What changed

The Department of Justice published a Federal Register notice announcing a 60-day public comment period on proposed revisions to the Drug Use Statement, a previously approved information collection under OMB No. 1117-0063. The document describes the standard Paperwork Reduction Act process for modifying existing DEA forms related to drug use documentation requirements.

Affected parties, including pharmaceutical manufacturers and healthcare providers that submit Drug Use Statements to DEA, may wish to review the proposed revisions and submit comments by the June 16, 2026 deadline. This is a routine administrative update to paperwork requirements and does not create new substantive compliance obligations.

Archived snapshot

Apr 17, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

Legal Status This site displays a prototype of a “Web 2.0” version of the daily
Federal Register. It is not an official legal edition of the Federal
Register, and does not replace the official print version or the official
electronic version on GPO’s govinfo.gov.

The documents posted on this site are XML renditions of published Federal
Register documents. Each document posted on the site includes a link to the
corresponding official PDF file on govinfo.gov. This prototype edition of the
daily Federal Register on FederalRegister.gov will remain an unofficial
informational resource until the Administrative Committee of the Federal
Register (ACFR) issues a regulation granting it official legal status.
For complete information about, and access to, our official publications
and services, go to About the Federal Register on NARA's archives.gov.

The OFR/GPO partnership is committed to presenting accurate and reliable
regulatory information on FederalRegister.gov with the objective of
establishing the XML-based Federal Register as an ACFR-sanctioned
publication in the future. While every effort has been made to ensure that
the material on FederalRegister.gov is accurately displayed, consistent with
the official SGML-based PDF version on govinfo.gov, those relying on it for
legal research should verify their results against an official edition of
the Federal Register. Until the ACFR grants it official status, the XML
rendition of the daily Federal Register on FederalRegister.gov does not
provide legal notice to the public or judicial notice to the courts.

Legal Status

Notice

Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Drug Use Statement

A Notice by the Justice Department on 04/17/2026

  • 1.

1.
This document has a comment period that ends in 60 days.
(06/16/2026)

Thank you for taking the time to create a comment. Your input is important.

Once you have filled in the required fields below you can preview and/or submit your comment to the Justice Department for review. All comments are considered public and will be posted online once the Justice Department has reviewed them.

You can view or you may also comment via Regulations.gov at /documents/2026/04/17/2026-07520/agency-information-collection-activities-proposed-ecollection-ecomments-requested-revision-of-a.

It appears that you have attempted to comment on this document before
so we've restored your progress.
.
1.
2. Comment * What is your comment about? Upload File(s) Note: You can attach your comment as a file and/or attach supporting
documents to your comment. Attachment Requirements.

Email this will NOT be posted on regulations.gov

Opt to receive email confirmation of submission and tracking number? Tell us about yourself! I am... * An Individual An Organization Anonymous First Name * Last Name * City Region State Alabama Alaska American Samoa Arizona Arkansas California Colorado Connecticut Delaware District of Columbia Florida Georgia Guam Hawaii Idaho Illinois Indiana Iowa Kansas Kentucky Louisiana Maine Maryland Massachusetts Michigan Minnesota Mississippi Missouri Montana Nebraska Nevada New Hampshire New Jersey New Mexico New York North Carolina North Dakota Ohio Oklahoma Oregon Pennsylvania Puerto Rico Rhode Island South Carolina South Dakota Tennessee Texas Utah Vermont Virgin Islands Virginia Washington West Virginia Wisconsin Wyoming Zip Country Afghanistan Åland Islands Albania Algeria American Samoa Andorra Angola Anguilla Antarctica Antigua and Barbuda Argentina Armenia Aruba Australia Austria Azerbaijan Bahamas Bahrain Bangladesh Barbados Belarus Belgium Belize Benin Bermuda Bhutan Bolivia, Plurinational State of Bonaire, Sint Eustatius and Saba Bosnia and Herzegovina Botswana Bouvet Island Brazil British Indian Ocean Territory Brunei Darussalam Bulgaria Burkina Faso Burundi Cambodia Cameroon Canada Cape Verde Cayman Islands Central African Republic Chad Chile China Christmas Island Cocos (Keeling) Islands Colombia Comoros Congo Congo, the Democratic Republic of the Cook Islands Costa Rica Côte d'Ivoire Croatia Cuba Curaçao Cyprus Czech Republic Denmark Djibouti Dominica Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Falkland Islands (Malvinas) Faroe Islands Fiji Finland France French Guiana French Polynesia French Southern Territories Gabon Gambia Georgia Germany Ghana Gibraltar Greece Greenland Grenada Guadeloupe Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Heard Island and McDonald Islands Holy See (Vatican City State) Honduras Hong Kong Hungary Iceland India Indonesia Iran, Islamic Republic of Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Korea, Democratic People's Republic of Korea, Republic of Kuwait Kyrgyzstan Lao People's Democratic Republic Latvia Lebanon Lesotho Liberia Libya Liechtenstein Lithuania Luxembourg Macao Macedonia, the Former Yugoslav Republic of Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Martinique Mauritania Mauritius Mayotte Mexico Micronesia, Federated States of Moldova, Republic of Monaco Mongolia Montenegro Montserrat Morocco Mozambique Myanmar Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria Niue Norfolk Island Northern Mariana Islands Norway Oman Pakistan Palau Palestine, State of Panama Papua New Guinea Paraguay Peru Philippines Pitcairn Poland Portugal Puerto Rico Qatar Réunion Romania Russian Federation Rwanda Saint Barthélemy Saint Helena, Ascension and Tristan da Cunha Saint Kitts and Nevis Saint Lucia Saint Martin (French part) Saint Pierre and Miquelon Saint Vincent and the Grenadines Samoa San Marino Sao Tome and Principe Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Sint Maarten (Dutch part) Slovakia Slovenia Solomon Islands Somalia South Africa South Georgia and the South Sandwich Islands South Sudan Spain Sri Lanka Sudan Suriname Svalbard and Jan Mayen Swaziland Sweden Switzerland Syrian Arab Republic Taiwan, Province of China Tajikistan Tanzania, United Republic of Thailand Timor-Leste Togo Tokelau Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States United States Minor Outlying Islands Uruguay Uzbekistan Vanuatu Venezuela, Bolivarian Republic of Viet Nam Virgin Islands, British Virgin Islands, U.S. Wallis and Futuna Western Sahara Yemen Zambia Zimbabwe Phone Organization Type * Company Organization Federal State Local Tribal Regional Foreign U.S. House of Representatives U.S. Senate Organization Name * You are filing a document into an official docket. Any personal
information included in your comment text and/or uploaded
attachment(s)
may be publicly viewable on the web. I read and understand the statement above.

  1. Please review the Regulations.gov privacy notice and user notice.
  2. Document Details Published Content - Document Details Agency Department of Justice Agency/Docket Number OMB Number 1117-0063 Document Citation 91 FR 20704 Document Number 2026-07520 Document Type Notice Pages 20704-20705 (2 pages) Publication Date 04/17/2026 Published Content - Document Details
  • PDF Official Content
  • Document Details Published Content - Document Details Agency Department of Justice Agency/Docket Number OMB Number 1117-0063 Document Citation 91 FR 20704 Document Number 2026-07520 Document Type Notice Pages 20704-20705 (2 pages) Publication Date 04/17/2026 Published Content - Document Details
  • Document Dates Published Content - Document Dates Comments Close 06/16/2026 Dates Text Comments are encouraged and will be accepted for 60 days until June 16, 2026. Published Content - Document Dates
  • Table of Contents Enhanced Content - Table of Contents This table of contents is a navigational tool, processed from the
    headings within the legal text of Federal Register documents.
    This repetition of headings to form internal navigation links
    has no substantive legal effect.

    -

    -

    -

    • Enhanced Content - Table of Contents
  • Related Documents Enhanced Content - Related Documents FederalRegister.gov uses the agency dockets published with the document to display related documents.

| OMB Number 1117-0063
(3 Documents) |
| --- |
| Date | | Action | Title |
| | 2026-04-17 | 60-Day notice. | Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Drug Use Statement |
| | 2026-01-28 | 30-Day notice. | Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Drug Use Statement |
| | 2025-11-24 | 60-Day notice. | Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Previously Approved Collection; Drug Use Statement |

Enhanced Content - Related Documents

  • Public Comments Enhanced Content - Public Comments Comments are being accepted - .

Enhanced Content - Public Comments
- Regulations.gov Data Enhanced Content - Regulations.gov Data Additional information is not currently available for this document.

Enhanced Content - Regulations.gov Data

- Sharing Enhanced Content - Sharing Shorter Document URL https://www.federalregister.gov/d/2026-07520 Email Email this document to a friend Enhanced Content - Sharing

  • Print Enhanced Content - Print
    • Enhanced Content - Print
  • Other Formats Enhanced Content - Other Formats This document is also available in the following formats:

JSON Normalized attributes and metadata XML Original full text XML MODS Government Publishing Office metadata More information and documentation can be found in our developer tools pages.

Enhanced Content - Other Formats
- Public Inspection Public Inspection This PDF is FR Doc. 2026-07520 as it appeared on Public Inspection on
04/16/2026 at 8:45 am.

It was viewed
18
times while on Public Inspection.

If you are using public inspection listings for legal research, you
should verify the contents of the documents against a final, official
edition of the Federal Register. Only official editions of the
Federal Register provide legal notice of publication to the public and judicial notice
to the courts under 44 U.S.C. 1503 & 1507.
Learn more here.

Public Inspection
Published Document: 2026-07520 (91 FR 20704) This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Document Headings Document headings vary by document type but may contain
the following:

  1. the agency or agencies that issued and signed a document
  2. the number of the CFR title and the number of each part the document amends, proposes to amend, or is directly related to
  3. the agency docket number / agency internal file number
  4. the RIN which identifies each regulatory action listed in the Unified Agenda of Federal Regulatory and Deregulatory Actions See the Document Drafting Handbook for more details.
Department of Justice
  1. [OMB Number 1117-0063]

AGENCY:

Drug Enforcement Administration, Department of Justice.

ACTION:

60-Day notice.

SUMMARY:

The Drug Enforcement Administration, Department of Justice (DOJ), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995.

DATES:

Comments are encouraged and will be accepted for 60 days until June 16, 2026.

FOR FURTHER INFORMATION CONTACT:

If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Benjamin Inks, Writer/Editor, Office of Compliance, Policy Administration Section 700 Army Navy Drive, Arlington, VA 22202, telephone: 571-672-4524, email: Benjamin.B.Inks@dea.gov.

SUPPLEMENTARY INFORMATION:

Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points:

—Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility;

—Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used;

—Evaluate whether and if so how the quality, utility, and clarity of the information to be collected can be enhanced; and

—Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses.

Abstract: The Drug Enforcement Administration (DEA) is a federal law enforcement agency charged with enforcing the controlled substances laws and regulations of the United States. Its principal responsibilities include investigation and prosecution of major violators of controlled substances laws.

Because of the nature of DEA's mission, and its status as a law enforcement agency, past use of illegal drugs by potential employees presents special concerns, and therefore the agency evaluates a job applicant's illegal drug use and abuse during the application process. Executive Order 12564 is supported in the DEA Pre-Employment Drug Policy that a history of illegal drug use or abuse may be a disqualification for employment with DEA.

The content and questions of this previously approved form have been edited to eliminate confusion between job applicants and polygraphers before a pre-employment polygraph examination. The DEA Pre-Employment Drug Policy and DEA-200 form asks applicants to acknowledge their understanding of those requirements to move forward in the employment process.

Overview of This Information Collection

  1. Type of Information Collection: Revision.

  2. The Title of the Form/Collection: Drug Enforcement Administration Pre-Employment Drug Policy Notification and Acknowledgement.

  3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: Form number: DEA-200. The sponsoring component is the Drug Enforcement Administration.

  4. Affected public who will be asked or required to respond, as well as the obligation to respond: DEA job applicants are asked to complete the form. While not mandatory, an applicant can be disqualified in the hiring process for failing to provide the requested acknowledgement.

  5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The total or estimated number of respondents for the DEA-200 is 5,000. The time per response is 7 minutes.

  6. An estimate of the total annual burden (in hours) associated with the collection: The total annual burden hours for this collection is 583 hours. ( printed page 20705)

  7. An estimate of the total annual cost burden associated with the collection, if applicable: $19,040.78.

| Activity | Number of
respondents | Frequency
(per annually) | Total
annual
responses | Time per
response
(minutes) | Total
annual
burden
(hours) | Wage rate | Annualized
burden |
| --- | --- | --- | --- | --- | --- | --- | --- |
| DEA Form 200 | 5,000 | 1 | 5,000 | 7 | 583 | $32.66 | $19,040.78 |
| Unduplicated Totals | 5,000 | 1 | 5,000 | 7 | 583 | 32.66 | 19,040.78 |
If additional information is required contact: Darwin Arceo, Department Clearance Officer, United States Department of Justice, Justice Management Division, Enterprise Portfolio Management, Two Constitution Square, 145 N Street NE, 4W-218, Washington, DC.

Dated: April 15, 2026.

Darwin Arceo,

Department Clearance Officer for PRA, U.S. Department of Justice.

[FR Doc. 2026-07520 Filed 4-16-26; 8:45 am]

BILLING CODE 4410-09-P

Published Document: 2026-07520 (91 FR 20704)

Get daily alerts for FR: Justice Department

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from Justice Department.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
Justice Department
Published
April 17th, 2026
Comment period closes
June 16th, 2026 (60 days)
Compliance deadline
June 16th, 2026 (60 days)
Instrument
Notice
Legal weight
Non-binding
Stage
Consultation
Change scope
Minor
Document ID
91 FR 20704 / OMB Number 1117-0063
Docket
OMB Number 1117-0063

Who this affects

Applies to
Pharmaceutical companies Healthcare providers Drug manufacturers
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Drug use documentation DEA registration paperwork Information collection
Geographic scope
United States US

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Regulatory Affairs
Topics
Public Health Healthcare Data Privacy

Get alerts for this source

We'll email you when FR: Justice Department publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!